Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1
复制标题
DOI:
10.1016/s0014-2999(01)01491-1
复制
发表时间:
2001-12-14
影响因子:
5
通讯作者:
Maggio, R
中科院分区:
文献类型:
--
作者:
Chiarenza, A;Scarselli, M;Maggio, R
We tested the ability of dopamine, apomorphine, phenylethylamine and pergolide to inhibit the proliferation of fetal calf serum-stimulated human breast cancer (MCF)-7 cells. While the first three compounds were able to block the proliferation of MCF-7 cells, pergolide failed to do so (up to 100 muM). The inhibitory effect of dopamine, apomorphine and phenylethylamine was also evident in serum-starved insulin-stimulated MCF-7 cells. Apomorphine also inhibited the proliferation of the human oestrogen receptor-negative breast cancer (MDA-MB231) and prostate carcinoma (LNCaP) cell lines. In a second set of experiments, we measured the ability of dopamine, apomorphine, phenylethylamine and pergolide to inhibit the phosphorylation (or increase the dephosphorylation) of the insulin receptor substrate (IRS)-1, a major intracellular substrate of the insulin-like growth factor (IGF)-1 receptor. Dopamine, apomorphine and phenylethylamine all reduced to zero the level of phosphorylated IRS-1 with potencies ranging between 0.01 and 1 muM. Finally, we found that fibroblasts from IRS-1 null (-/-) mice were less sensitive to the anti-proliferative effect of apomorphine compared to fibroblasts from wild type-mice, suggesting that the inhibition of IRS-1 phosphorylation by apomorphine is an important aspect of the activity of this compound. (C) 2001 Elsevier Science B.V All fights reserved.